Advertisement

Topics

Meningococcal Conjugates Vaccine - Biotech, Pharma and Life Science Channel

13:48 EDT 25th July 2016 | BioPortfolio

PubMed Articles [1837 Associated PubMed Articles listed on BioPortfolio]

African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.

African horse sickness (AHS) is a hemorrhagic viral fever of horses. It is the only equine disease for which the World Organization for Animal Health has introduced specific guidelines for member coun...

Imitation dynamics of vaccine decision-making behaviours based on the game theory.

Based on game theory, we propose an age-structured model to investigate the imitation dynamics of vaccine uptake. We first obtain the existence and local stability of equilibria. We show that Hopf bif...

In silico proposition to predict cluster of B- and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni.

Campylobacter jejuni is the one of the leading causes of bacterial diarrheal illness worldwide. This study aims to design specific epitopes for the utility of designing peptide vaccine(s) against C. j...

Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine.

Mucosal immune system plays a very important role in antiviral immune response. We prepared Newcastle disease viruses (NDV) encapsulated in N-2-hydroxypropyl trimethyl ammonium chloride chitosan (N-2-...

Engaging Transgender People in NIH-Funded HIV/AIDS Clinical Trials Research.

In 2009, the National Institutes of Health recognized the need to expand knowledge of lesbian, gay, bisexual, and transgender (LGBT) health and commissioned the Institute of Medicine to report on the ...

In vitro responses of chicken macrophage-like monocytes following exposure to pathogenic and non-pathogenic E. coli ghosts loaded with a rational design of conserved genetic materials of influenza and Newcastle disease viruses.

Avian influenza virus (AIV) and Newcastle disease virus (NDV) are two important viral diseases in the poultry industry. Therefore, new disease-fighting strategies, especially effective genetic vaccina...

Emerging Streptococcus pneumoniae Strains Colonizing the Nasopharynx in Children After 13-valent Pneumococcal Conjugate Vaccination in Comparison to the 7-valent Era, 2006-2015.

After introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the United States in 2000, emergence of replacement serotypes occurred, leading to the introduction of a 13-valent pneumococ...

Incidence and consequences of varicella in children treated for cancer in Guatemala.

Varicella-zoster virus infection is associated with significant morbidity and mortality in immune-compromised children, despite treatment with antiviral agents. Universal varicella vaccine programs ha...

Vaccinations for the Older Adult.

Vaccine response declines with age, but currently recommended vaccines are safe and effective in reducing, if not preventing, disease altogether. Over the last decade, advancements in vaccine immunoge...

Herpes Zoster.

Herpes zoster causes significant suffering owing to acute and chronic pain or postherpetic neuralgia (PHN). Varicella-zoster virus-induced neuronal destruction and inflammation causes the principal pr...

News Articles [2560 Associated News Articles listed on BioPortfolio]

VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate

Valneva Announces Successful Completion of Phase II  for Clostridium Difficile Vaccine Candidate Final Phase II results of Valneva's Clostridium difficile vaccine candidate confirm posit...

MHRA backs Sanofi Pasteur MSD’s quadrivalent flu vaccine

Sanofi Pasteur MSD UK says that the UK’S Medicines and Healthcare products Regulatory Agency (MHRA)…

Flu vaccine may reduce risk of death for type 2 diabetes patients

The flu vaccine may reduce the likelihood of being hospitalised with stroke and heart failure in people with type 2 diabetes, according to new research.

Merck Reports Regulatory Milestones For Its Investigational Vaccine For Ebola

WHITEHOUSE STATION (dpa-AFX) - Merck (MRK) announced the company's investigational vaccine for Ebola Zaire, V920, has been granted Breakthrough Therapy Designation from the U.S. FDA, and PRIME (PR...

Flu vaccine may help keep diabetics out of the hospital

(Reuters Health) - People with diabetes who get the flu vaccine may be less likely to wind up hospitalized for cardiovascular or respiratory problems, a recent study suggests.

Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced two regulatory milestones for the company's investigational vaccine for Ebola Zaire, V920 (rVSV?G-ZEBOV-GP, liv...

BRIEF-Valneva successfully completes Clostridium Difficile phase II trial

* Announces successful completion of phase II for clostridium difficile vaccine candidate

MHRA approves Sanofi Pasteur MSD’s four-strain influenza vaccine for UK use

Sanofi Pasteur MSD has announced the approval of the latest addition to its family of influenza vaccines in the UK: the quadrivalent influenza vaccine (split virion, inactivated). The vaccine contains...

Vaccine Strategy Induces Antibodies That Target Multiple Influenza Viruses

NewsScientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans.

“Mind-Altering” Parasite Proteins Trigger Antitumor Response to Ovarian Cancer

Researchers say they have identified the specific proteins secreted by the parasite Toxoplasma gondii that cause the immune system in mice to attack established ovarian tumors. The study (...

Events [0 Results]

None

Companies [109 Associated Companies listed on BioPortfolio]

IDT Biologika and CMC Biologics

IDT Biologika is an innovative life science company headquartered in Dessau, Germany with extensive expertise in research, development and manufacturing of vaccines, and in additi...

SynAffix

SynAffix is a protein engineering company located in Oss (the Netherlands), focused on the development of next-generation Antibody-Drug Conjugates (ADCs) for targeted cancer and other diseases. SynA...

TOMTEC

Tomtec has succeeded since 1967 by working with its clients to help solve their liquid handling needs. From 1967 to 1981, the Company had essentially one employee, Tom Astle. From 1967 to 1971, the Co...

PsiOxus Therapeutics Ltd.

PsiOxus Therapeutics is an Oxford, UK-based development stage biotechnology company with a particular focus on immune therapeutics in oncology. PsiOxus has developed a pate...

Neon Therapeutics

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allo...

VaxAlta Inc.

VaxAlta is a leading glycoconjugate vaccine research and development company based in Edmonton, Alberta. Founded in 2013, the company is focused on developing sugar-based, effecti...

IDT Biologika

IDT Biologika is an innovative, privately-held life science company with more than 94 years history and expertise in Research, Development and Manufacturing of biologics for the g...

ImmusanT, Inc.

ImmusanT is a privately held biotechnology company focused on restoring tolerance to gluten in celiac disease by harnessing new discoveries in immunology that aim to improve diagn...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented ...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

Clinical Trials [2622 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy Adults

Background: The Zika virus is passed to humans by infected mosquitos. It usually causes fever, rash, joint pain, and red eyes. Recently, some cases of microcephaly (abnormally small head)...

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

This Phase 3 study evaluates the safety, immunogenicity and lot-to lot consistency of 3 lots of aH5N1c vaccine for pandemic avian influenza, in approximately 2394 healthy adults ≥18 year...

Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children

Double blind, randomized, controlled, dose-escalation Phase 1 clinical trial in hookworm-exposed children aged 6 to 10 years living in the area of Lambaréné, Gabon. Children will receive...

Safety and Efficacy Study of Type 2 Herpes Simplex Virus Therapeutic DNA Vaccine

The purpose of this trial is the evaluate the safety and efficacy of a therapeutic DNA vaccine in adults with type 2 herpes simplex virus (i.e., genital herpes).

Mobile Health Intervention in Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men

This pilot trial studies how well a mobile health (mHealth) human papillomavirus (HPV) vaccine intervention works in increasing HPV vaccine coverage among young adult gay and bisexual men....

A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls

Cervical cancer is the most common cancer in women aged 15-44 years in East Africa, and mortality rates are very high. HPV vaccines are most effective if given to girls who have not yet ac...

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

This phase I clinical trial studies the side effects of sirolimus and NY-ESO-1 protein with MIS416 in treating patients stage II-IV ovarian, fallopian tube, or primary peritoneal cancer. S...

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

This Phase 2 Quadrivalent VLP Vaccine study is intended to replicate and extend the immunogenicity and safety results obtained in earlier Phase 1-2 and Phase 2 studies. The study is being ...

Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Determine the Safety and Immunogenicity of an Adenoviral-Vector Based Respiratory Syncytial Virus (RSV) F Pro...

Homeopathic Vaccine RCT

The purpose of the study is to compare the immunological response of homeopathic vaccines to placebo and to conventional vaccines in healthy young adults.

Videos

None available.

Medical and Biotech [MESH] Definitions

A combined vaccine used to prevent infection with diphtheria and tetanus toxoid. This is used in place of DTP vaccine (DIPHTHERIA-TETANUS-PERTUSSIS VACCINE) when PERTUSSIS VACCINE is contraindicated.

A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed)

A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine.

A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed)

Quick Search
Advertisement
 
review and buy Meningococcal Conjugates Vaccine market research data and corporate reports here

Channels Quicklinks